Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pearl Drops comparative cleaning claims referencing Rembrandt banned -- consent decree.

This article was originally published in The Rose Sheet

Executive Summary

CARTER-WALLACE BANNED FROM USING COMPARATIVE CLEANING CLAIMS in ads comparing its Pearl Drops products to Den-Mat's Rembrandt Whitening toothpaste under a consent order recently handed down by U.S. District Court for the Southern District of New York Judge Kimba Wood. The order was issued in response to a suit filed by Den-Mat on May 10, 1994 alleging false and deceptive advertising and unfair competition. Den-Mat's suit claims that the data used to substantiate Carter-Wallace's comparative advertising claims were "based on invalid and unreliable laboratory testing."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel